𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Blood–brain barrier efflux transport

✍ Scribed by Pamela L. Golden; Gary M. Pollack

Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
193 KB
Volume
92
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.

✦ Synopsis

Efflux transport at the blood-brain barrier (BBB) limits the brain tissue exposure to a variety of potential therapeutic agents, including compounds that are relatively lipophilic and would be predicted to permeate the endothelial lining of the brain microvasculature. Recent advances in molecular and cell biology have led to identification of several specific transport systems at the blood-brain interface. Refinement of classical pharmacokinetic experimentation has allowed assessment of the structural specificity of transporters, the impact of efflux transport on brain tissue exposure, and the potential for drug-drug interactions at the level of BBB efflux transport. The objective of this minireview is to summarize efflux transporter characteristics (location, specificity, and potential inhibition) for transport systems identified in the BBB. A variety of experimental approaches available to ascertain or predict the impact of efflux transport on net brain tissue uptake of substrates also are presented. The potential impact of efflux transport on the pharmacodynamics of agents acting in the central nervous system are illustrated. Finally, general issues regarding the role of identifying efflux transport as part of the drug development process are discussed.

📜 SIMILAR VOLUMES

Blood–brain barrier transport of naloxon
Blood–brain barrier transport of naloxone does not involve P-glycoprotein-mediated efflux
✍ Toyofumi Suzuki; Mariko Miyata; Chika Zaima; Takayuki Furuishi; Toshiro Fukami; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

The blood-brain barrier (BBB) transport of naloxone, a potent and specific opioid antagonist, was investigated in rats using the brain uptake index method and the brain efflux index method. The apparent influx clearance of [ 3 H]naloxone across the BBB was 0.305 mL/min/g brain. [ 3 H]naloxone was el

Contribution of P-glycoprotein to bunitr
Contribution of P-glycoprotein to bunitrolol efflux across blood–brain barrier
✍ Jo Matsuzaki; Chika Yamamoto; Tetsuo Miyama; Hitomi Takanaga; Hirotami Matsuo; H 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

In this study, we investigated the mechanism of the blood -brain barrier (BBB) transport of bunitrolol (BTL), as a model of i-blocker, in vivo and in vitro. In order to define the contribution of P-glycoprotein (P-gp) to the active efflux of BTL from brain to blood, we examined the in vivo brain dis

Evaluation of drug efflux transporter li
Evaluation of drug efflux transporter liabilities of darifenacin in cell culture models of the blood–brain and blood–ocular barriers
✍ Donald W. Miller; Martha Hinton; Fang Chen 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB

## Abstract ## Aims The objective of the present study was to evaluate drug efflux transporter interactions of darifenacin and examine the impact of such transporter interactions on darifenacin permeability in an __in vitro__ model of the blood–brain barrier (BBB) and blood–ocular barrier (BOB).

Regional transport of phenylalanine acro
Regional transport of phenylalanine across the blood-brain barrier
✍ Michael Pollay 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 476 KB

## Abstract In adult rats, using the single‐pass brain uptake technique with a tritiated water standard, L‐phenylalanine was shown to enter brain across the blood‐brain barrier (BBB) by both a saturable and diffusionary process. A kinetic analysis of the data revealed Michaelis constant (K~a~) of 0